Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
AstraZeneca
Colorcon
McKinsey
McKesson

Last Updated: June 27, 2022

Investigational Drug Information for fluoruracil


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for fluoruracil?

fluoruracil is an investigational drug.

There have been 29 clinical trials for fluoruracil. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2008.

The most common disease conditions in clinical trials are Breast Neoplasms, Colorectal Neoplasms, and Stomach Neoplasms. The leading clinical trial sponsors are University Hospital of Crete, Hellenic Oncology Research Group, and Gruppo Oncologico del Nord-Ovest.

Recent Clinical Trials for fluoruracil
TitleSponsorPhase
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal CarcinomaKuwait Cancer Control CenterPhase 3
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 1
Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm PatientsGruppo Oncologico Italiano di Ricerca ClinicaPhase 2

See all fluoruracil clinical trials

Clinical Trial Summary for fluoruracil

Top disease conditions for fluoruracil
Top clinical trial sponsors for fluoruracil

See all fluoruracil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
AstraZeneca
Colorcon
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.